{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Safety+in+Asthma+Patients", "query": { "condition": "Safety in Asthma Patients" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 144, "total_pages": 15, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Safety+in+Asthma+Patients&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-26T05:27:24.346Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03170271", "title": "A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Benralizumab (Medi-563)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 660, "start_date": "2017-07-07", "completion_date": "2020-10-21", "has_results": true, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 100, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 87 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03170271" }, { "nct_id": "NCT01591044", "title": "A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "R940343 1mg", "type": "DRUG" }, { "name": "R940343 2mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rigel Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 301, "start_date": "2012-07", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2016-09-29", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 51, "location_summary": "Fullerton, California • Los Angeles, California • Mission Viejo, California + 43 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01591044" }, { "nct_id": "NCT07665892", "title": "Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Safety in Asthma Patients" ], "interventions": [ { "name": "ASY202", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Aspeya, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2026-05-26", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 2, "location_summary": "Glendale, Arizona • San Antonio, Texas", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07665892" }, { "nct_id": "NCT04847674", "title": "A Study to Test if TEV-53275 is Effective in Relieving Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "TEV-53275 Dose A", "type": "DRUG" }, { "name": "TEV-53275 Dose B", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2021-05-04", "completion_date": "2022-04-28", "has_results": true, "last_update_posted_date": "2023-06-08", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 77, "location_summary": "Hoover, Alabama • Peoria, Arizona • Phoenix, Arizona + 62 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04847674" }, { "nct_id": "NCT01057498", "title": "Safety Study of Nebulized RNS60 to Treat Asthma.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "RNS60", "type": "DRUG" }, { "name": "RNS60 - single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Revalesio Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 36, "start_date": "2010-05", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2012-01-12", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 2, "location_summary": "Cypress, California • Stanford, California", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01057498" }, { "nct_id": "NCT01197794", "title": "Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma Patients" ], "interventions": [ { "name": "AZD1981", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1144, "start_date": "2010-10", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2013-11-06", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 19, "location_summary": "Fullerton, California • Los Angeles, California • Mission Viejo, California + 16 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01197794" }, { "nct_id": "NCT00635505", "title": "Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "albuterol HFA (Armstrong's)", "type": "DRUG" }, { "name": "albuterol HFA (Proventil HFA)", "type": "DRUG" }, { "name": "HFA placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 300, "start_date": "2007-09", "completion_date": "2008-08", "has_results": false, "last_update_posted_date": "2013-07-15", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 42, "location_summary": "Mobile, Alabama • Huntington Beach, California • Long Beach, California + 34 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00635505" }, { "nct_id": "NCT01581177", "title": "Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol DPI 25 mcg/inh", "type": "DRUG" }, { "name": "Albuterol DPI 90 mcg/inh", "type": "DRUG" }, { "name": "Placebo DPI", "type": "DRUG" }, { "name": "Albuterol MDI 90 mcg/inh", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 23, "start_date": "2012-04", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2017-05-19", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 4, "location_summary": "San Jose, California • Medford, Oregon • New Braunfels, Texas + 1 more", "locations": [ { "city": "San Jose", "state": "California" }, { "city": "Medford", "state": "Oregon" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01581177" }, { "nct_id": "NCT01290887", "title": "Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eosinophilic Asthma" ], "interventions": [ { "name": "Reslizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 1052, "start_date": "2011-06", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2016-06-06", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 48, "location_summary": "Scottsdale, Arizona • Anaheim, California • Fountain Valley, California + 39 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01290887" }, { "nct_id": "NCT00529529", "title": "Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol 300 μg", "type": "DRUG" }, { "name": "Salmeterol 50 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Placebo to salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 805, "start_date": "2007-09", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2011-08-29", "last_synced_at": "2026-06-26T05:27:24.346Z", "location_count": 56, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Encinitas, California + 44 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00529529" } ] }